FP

Realta Wealth Names Experienced Finance Leader Tim Bowman As Chief Financial Officer

Retrieved on: 
Martedì, Marzo 12, 2024
Series 4, Certified Public Accountant, Growth, Finance, CFO, Bowman, Accounting, Executive Committee, KCG Holdings, FP, FINRA, CPA, Management

WILMINGTON, Del., March 12, 2024 /PRNewswire/ -- Realta Wealth, an exclusive independent wealth management firm, announced the appointment of Tim Bowman, CPA, as Chief Financial Officer to help the firm's executive team deliver on its growth vision and strategy. He reports to Realta Wealth CEO Kevin Keefe.

Key Points: 
  • Seasoned Leader to Drive Growth, Strengthen Firm Leadership as it Builds on Rebrand Efforts
    WILMINGTON, Del., March 12, 2024 /PRNewswire/ -- Realta Wealth, an exclusive independent wealth management firm, announced the appointment of Tim Bowman, CPA, as Chief Financial Officer to help the firm's executive team deliver on its growth vision and strategy.
  • "Tim has a stellar track record of helping financial services firms achieve outsized growth, and doing so with fiscally sound approaches," Keefe said.
  • Bowman will oversee all of Realta's financial operations, including accounting, FP&A, commissions, and financial reporting.
  • Bowman is a Certified Public Accountant and holds multiple FINRA licenses, including Series 4, 7, 24, 27, and 63.

EQS-News: Francotyp-Postalia Holding AG: Supervisory Board appoints Friedrich Conzen as new Chairman of the Management Board

Retrieved on: 
Mercoledì, Marzo 13, 2024
Supervisory board, FP, Growth, Electronics, FUTURE, Software as a service, Kearney (consulting firm), Cryptocurrency

Berlin, 26 February 2024 The Supervisory Board of Francotyp-Postalia Holding AG has appointed Friedrich (Fritz) Conzen as a new member and Chairman of the Management Board with effect as of 1 March 2024.

Key Points: 
  • Berlin, 26 February 2024 The Supervisory Board of Francotyp-Postalia Holding AG has appointed Friedrich (Fritz) Conzen as a new member and Chairman of the Management Board with effect as of 1 March 2024.
  • He succeeds Carsten Lind, who has energetically led the company since 2020 and will leave the Management Board in agreement with the Supervisory Board on March 1st, 2024.
  • Carsten Lind says: ”In 2021 we initiated FUTURE@FP with the promise to reverse the trend of FP declining and making losses and to build a digital business.
  • As new CEO, Friedrich Conzen (48) is expected to build on the strategy and help further grow the digital business, supported by cash flow from the core mailing business globally.

EQS-News: Francotyp-Postalia Holding AG: Extension of the syndicated loan

Retrieved on: 
Mercoledì, Marzo 13, 2024
UniCredit, EUR, Deutsche Bank, FP, Landesbank

Berlin, February 29, 2024 Francotyp-Postalia Holding AG (ISIN DE000FPH9000) has amended its syndicated loan agreement with effect from February 26th, 2024.

Key Points: 
  • Berlin, February 29, 2024 Francotyp-Postalia Holding AG (ISIN DE000FPH9000) has amended its syndicated loan agreement with effect from February 26th, 2024.
  • The agreement was signed with the established banking consortium consisting of Landesbank Baden-Württemberg as Facility Agent, Deutsche Bank AG and UniCredit Bank GmbH.
  • The syndicated loan has a total volume of EUR 55 million and a term of three years with twofold option to extend it by one year.
  • The new syndicated loan agreement thus provides FP with a good basis for driving forward the Group's strategy and profitable growth in the coming years.

Gen II Fund Services Expands Digital Solutions and Internal Operations Leadership Teams

Retrieved on: 
Martedì, Marzo 5, 2024
Investment, LP, Digital Solutions, FP, Gen, Marketing, Health, Growth, CPG, Sale, Treasury, Lead, EFront, Software as a service, CRM, Kwang, Finance, Biotechnology, Head, Cryptocurrency

“We are thrilled to welcome Ben Mazza to our team to take our digital innovation to new heights,” said Robert Caporale, President, Strategic & Digital Solutions at Gen II Fund Services.

Key Points: 
  • “We are thrilled to welcome Ben Mazza to our team to take our digital innovation to new heights,” said Robert Caporale, President, Strategic & Digital Solutions at Gen II Fund Services.
  • Kwang brings more than 20 years of strategic financial planning and analysis experience to his new role at Gen II.
  • Along with Kwang’s proven ability to build and lead FP&A functions will further strengthen our capabilities,” said Marlene Pelage, Chief Financial Officer at Gen II Fund Services.
  • “We are excited to welcome both to Gen II, and we look forward to leveraging their talents to drive our continued success.”

Health Catalyst to Participate in Upcoming Investor Conferences

Retrieved on: 
Lunedì, Marzo 4, 2024
Senior, FP, Barclays, Conference, HCAT

SALT LAKE CITY, March 04, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that members of leadership will participate in the following upcoming investor conferences:

Key Points: 
  • SALT LAKE CITY, March 04, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that members of leadership will participate in the following upcoming investor conferences:
    The Raymond James 45th Annual Institutional Investors Conference, being held in Orlando, including a fireside chat with Jason Alger, Chief Financial Officer, and Adam Brown, Senior Vice President of FP&A and Investor Relations, on Wednesday, March 6, 2024 at 11:00am ET.
  • The Barclays 26th Annual Global Healthcare Conference, being held in Miami, including a fireside chat with Dan Burton, Chief Executive Officer, and Jason Alger, Chief Financial Officer, on Thursday, March 14, 2024 at 10:15am ET.
  • The webcast link and related presentation materials will be available online at https://ir.healthcatalyst.com .

Madrigal Pharmaceuticals Provides Corporate Updates and Reports Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Mercoledì, Febbraio 28, 2024
CFO, Therapy, Research, Biotechnology, Accounting, FP, AASLD, PDUFA, Cirrhosis, Safety, Portola Pharmaceuticals, Abstract (summary), Liver disease, Health, Patient, Fibrosis, Medicine, Disease, NASH, G&A, Fatty liver disease, Pharmaceutical industry

Announced appointment of Mardi C. Dier as Chief Financial Officer

Key Points: 
  • Announced appointment of Mardi C. Dier as Chief Financial Officer
    Anticipates resmetirom to become the first medicine approved for NASH; PDUFA date March 14, 2024
    CONSHOHOCKEN, Pa., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (NASH), today provides a summary of corporate updates and reports fourth quarter and full year 2023 financial results.
  • She has held CFO positions at Portola Pharmaceuticals, Ultragenyx, and Acelyrin.
  • Five Madrigal health economic abstracts were presented at the NASH-TAG conference, which took place January 4-6, 2024 in Park City, Utah.
  • Financial Results for the Three and Twelve Months Ended December 31, 2023
    As of December 31, 2023, Madrigal had cash, cash equivalents and marketable securities of $634.1 million, compared to $358.8 million at December 31, 2022.

Madrigal Pharmaceuticals Appoints Mardi C. Dier as Chief Financial Officer

Retrieved on: 
Mercoledì, Febbraio 28, 2024
CFO, Acquisition, Therapy, Accounting, Prudential Securities, FP, FP&A, Growth, Senior advisor, Stanford University, KPMG, Portola Pharmaceuticals, Alexion, University, Patient, Novartis, NASH, Chiron Corporation, UCLA, Fatty liver disease, Biology, Management

CONSHOHOCKEN, Pa., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (NASH), today announced that Mardi C. Dier has been appointed Chief Financial Officer.

Key Points: 
  • CONSHOHOCKEN, Pa., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (NASH), today announced that Mardi C. Dier has been appointed Chief Financial Officer.
  • She joined Ultragenyx from Portola Pharmaceuticals (acquired by Alexion), where she served as Chief Financial Officer for 14 years and, most recently, as Chief Business Officer and Chief Financial Officer.
  • Ms. Dier joined Madrigal on February 27, 2024, as an employee in a Senior Advisor role to the Company’s current Chief Financial Officer, Alex Howarth, and will move into the Chief Financial Officer role on March 11, 2024.
  • “As we welcome Mardi to the Madrigal team, I’d also like to thank our outgoing Chief Financial Officer Alex Howarth for his substantial contributions to the Company,” said Bill Sibold.

Cosmin Pitigoi to Join Flywire as Chief Financial Officer

Retrieved on: 
Giovedì, Febbraio 22, 2024
CFO, Stellenbosch University, Travel, FP, SVP, Growth, B2B, Treasury, Risk, EBay, Barclays, Paidy, Drajna, Software, Santa Clara University, Education, Management

BOSTON, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Flywire Corporation (Nasdaq: FLYW) (Flywire), a global payments enablement and software company, today is announcing Cosmin Pitigoi will join the Company as Chief Financial Officer, beginning March 4, 2024.

Key Points: 
  • BOSTON, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Flywire Corporation (Nasdaq: FLYW) (Flywire), a global payments enablement and software company, today is announcing Cosmin Pitigoi will join the Company as Chief Financial Officer, beginning March 4, 2024.
  • Pitigoi will report to Flywire CEO Mike Massaro and will oversee Flywire’s accounting, financial planning and analysis, financial reporting, investor relations, internal audit, SEC reporting, tax, credit and risk and treasury functions.
  • “Given Flywire’s continued growth, we looked for a financial leader who could help us scale financial operations, optimize costs and improve our global footprint,” said Mike Massaro, CEO of Flywire.
  • “Cosmin brings decades of senior financial leadership and a proven track record in scaling organizations in complex global environments.

New Global Survey from Egon Zehnder Reveals the CFO Role is Bigger Than Ever, “Super CFOs” Continue to Evolve Beyond Finance, Aspire to be CEO

Retrieved on: 
Giovedì, Marzo 7, 2024
Consulting, Other Professional Services, Professional Services, Human Resources, CFO, Workload, Woman, FP, Female, Growth, ESG, Super, CFOS, M&A, Organization, Career, Male, Egon, Egon Zehnder, Management

The findings demonstrate a major evolution that has “Super CFOs” tackling new challenges, addressing new priorities, and aspiring even more for the CEO role.

Key Points: 
  • The findings demonstrate a major evolution that has “Super CFOs” tackling new challenges, addressing new priorities, and aspiring even more for the CEO role.
  • “Our study reveals a momentous evolution with ‘Super CFOs’ not just reacting to the changing business environment, but in fact driving it,” said Arun Dhingra, Global Head of Egon Zehnder’s CFO & Audit Chair Practice.
  • In particular, female CFOs were adamant about driving change—57% named this the key competency compared to 40% of male CFOs.
  • “Maintaining the role of corporate ‘Superhero’ is no easy feat,” said James Stark, lead author of the Super CFO Survey and consultant in the CFO & Audit Chair Practice at Egon Zehnder.

Q4 Inc. Announces Donna de Winter’s Retirement and Appointment of Leslie Lewis Westhaver as Chief Financial Officer

Retrieved on: 
Mercoledì, Marzo 6, 2024
Technology, Finance, Public Relations, Investor Relations, Communications, Professional Services, Software, Internet, Data Analytics, Environmental, Social and Governance (ESG), CFO, Acquisition, FP, Toronto Stock Exchange, Growth, Retirement, Q4, Financial management, Inc., Management

Q4 Inc. (“Q4” or the “Company”), today announced that Donna de Winter will retire from her position as Q4’s Chief Financial Officer after a distinguished career with the company.

Key Points: 
  • Q4 Inc. (“Q4” or the “Company”), today announced that Donna de Winter will retire from her position as Q4’s Chief Financial Officer after a distinguished career with the company.
  • Donna joined Q4 in 2019, and during her tenure as CFO and COO, she has made significant contributions to the Company's strategy planning, financial management and business development.
  • With Donna’s planned retirement, the company has appointed Leslie Westhaver as the new Chief Financial Officer, effective April 1, 2024.
  • Speaking on behalf of everyone at Q4, we thank Donna and wish her all the best in her retirement.”
    Mr. Heaps continued, “We welcome Leslie to Q4 as the new CFO.